The C. elegans vulva is formed by the descendants of three of six equipotent hypodermal blast cells. Two distinct vulval cell fates are specified by the actions of at least two conserved antagonistic signaling pathways, Ras and Notch. Mutations affecting these pathways cause the generation of ectopic vulval cells and a multivulva (Muv) phenotype.
To understand more about factors controlling the vulval cell-fate decision, we performed a screen for suppressors of the synthetic multivulva (synMuv) phenotype. The synMuv genes are grouped into at least three functionally redundant classes, A, B and C, that negatively regulate the specification of vulval cell fates. Animals mutant for one or more genes within the same class are non-Muv, whereas animals mutant for genes within any two classes are Muv. We identified
n2070 as a dominant suppressor of the synMuv phenotype of lin-15AB
(n765) mutants. Our gene dosage experiments suggest that the dominant phenotype conferred by
n2070 is caused by an increase in wild-type function. We mapped
n2070 to a 120-gene interval on LGIV and then used RNAi to inactivate the genes in the interval to eliminate the synMuv suppression phenotype of
n2070. RNAi of only
lst-3 (lst, lateral signaling target) reverted the synMuv suppression phenotype caused by
n2070. In a screen for cis-dominant suppressors of
n2070, we identified three independent isolates with nonsense mutations in
lst-3.
n2070 causes a proline-to-leucine substitution in a putative DNA-binding domain of LST-3.
The Greenwald laboratory identified
lst-3 as a possible transcriptional target of LAG-1, a
lin-12 Notch effector, and suggested that
lst-3 mediates the interplay between the Ras and Notch pathways.
lst-3 encodes a transcription factor similar to mammalian CARP-1, a cell cycle and apoptosis regulator. We isolated a deletion allele of
lst-3. This allele confers a synMuv phenotype in combination with mutations in class A or C but not with mutations in class B synMuv genes. Through gene expression analysis of gain-of-function and loss-of-function
lst-3 mutants, we have identified candidate LST-3 target genes. We will discuss how the modulation of
lst-3 function might affect the Ras and Notch pathways.